Distributes and trades nutraceutical and food ingredients in India, with FY26 consolidated revenue of Rs 214.83 crore, up 5.7% year-on-year supported by 7.1% volume growth. Sales are business-to-business to nutraceutical, food and supplement companies, with 15 new key customers added recently and 20 R&D projects in the pipeline. The wholly-owned subsidiary Easy Raw Materials Pvt Ltd (ERMPL) trades pharma products and nutritional supplements, while another wholly-owned subsidiary, Vinstar Biotech, develops in-house value-added ingredients and recorded Rs 223.43 lakh turnover in FY25-26. The group is moving from pure distribution into contract manufacturing through a CDMO facility under construction at JNPA SEZ, Navi Mumbai, with Rs 6,524 lakh in advance and open orders providing near-term visibility. Q1 FY27 revenue reached Rs 99.60 crore, roughly half of the previous full year. Listed on BSE SME in July 2025 via an IPO of Rs 6,448 lakh, with Rs 34.68 crore of net proceeds earmarked for the manufacturing facility, of which Rs 4.57 crore has been deployed. FY26 EBITDA margin compressed to 13.1% from 16.2% on US tariff uncertainties and export headwinds. AR · MarketPing reader · 2026-08-03
Revenue streams, as the annual report describes them. Nutraceutical and food ingredient distribution, Pharma products and nutritional supplements, In-house value-added ingredients, CDMO contract manufacturing. Asset-light nutraceutical distribution and trading, transitioning into integrated contract manufacturing
| ₹ crore · consolidated | FY26 |
|---|---|
| Revenue | 215 |
| EBITDA (ex other income) | — |
| margin % | — |
| Owners' profit | — |
| EPS, as reported (₹) | 17.26 |
| ROE % · ROCE % | — · 21.8 |
| Debt / equity (x) | — |
| Cash from operations | (3) |
| Capex | (5) |
| ₹ crore | Q2 FY26 | Q4 FY26 |
|---|---|---|
| Revenue | 103 | 112 |
| Profit before tax | 14 | 13 |
| Net profit | — | — |
| EPS (₹) | 9.50 | 7.86 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| EID PARRY INDIA LTD | 12,861 | 27.7 | 0.86 | 4.4 | 9.3 | 13.1 | 15.7 | 8.7 |
| MANORAMA INDUSTRIES LTD | 12,300 | 47.9 | 18.03 | 34.0 | 33.0 | 42.4 | — | 30.3 |
| ORKLA INDIA LIMITED | 8,048 | 27.3 | 2.93 | 18.1 | 10.4 | 13.1 | — | 19.9 |
| KRISHIVAL FOODS LIMITED | 963 | 40.6 | 4.82 | 24.9 | 11.1 | 13.1 | — | 13.0 |
| APIS INDIA LTD. | 716 | 2.8 | 3.60 | 18.7 | 12.7 | 15.5 | 7.4 | 11.9 |
| Pajson Agro India Limited | 502 | 38.6 | — | — | — | 24.0 | — | — |
| MEGASTAR FOODS LIMITED | 311 | 31.5 | 3.02 | 12.3 | 9.0 | 7.5 | 26.4 | 5.8 |
| Wardwizard Foods and Beverages | 237 | 40.1 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 10 Sept 2026 · CFO change at Chemkart India: Dalawai resigns, Asim Siddiqui appointed | management changes | high | — | — |
| 10 Sept 2026 · CFO resigns, new CFO appointed at Chemkart India | management changes | high | — | — |
| 10 Sept 2026 · Chemkart India appoints new CFO as Basavaraj Dalawai resigns | board shareholder meetings | medium | — | — |
| 2 Sept 2026 · Revised Annual Report FY2025-26 filed with typo corrections | general | low | — | — |
| 27 Aug 2026 · Notice of 7th AGM and e-voting info published in newspapers | compliance | minimal | — | — |
| 25 Aug 2026 · Annual Report FY2025-26 filed; revenue up 4.6 percent; new auditor proposed | results | high | — | — |
| 25 Aug 2026 · 7th AGM on 19 Sept 2026 via VC, e-voting 16-18 Sept, cut-off 12 Sept | board shareholder meetings | low | — | — |
| 25 Aug 2026 · Notice of 7th AGM on 19 Sep 2026, e-voting and auditor appointments | board shareholder meetings | low | — | — |
| 19 Aug 2026 · Chemkart India notifies 7th AGM on 19 September 2026 via video conferencing | compliance | minimal | — | — |
| 18 Aug 2026 · Board appoints Statutory and Secretarial Auditors for 5 years | management changes | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| 2.91 |
| — |
| 1.6 |
| 0.6 |
| — |
| 13.2 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 9.4 | 17.9 | 9 of 28 | 70% |
| ROCE | 20.7 | 12.1 | 6 of 31 | 83% |
| Market cap | 197 | 118 | 9 of 29 | 71% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
